You are here: Industry Insights > Novartis

News List

Novartis Launches MS Study that Allows Participants to Contribute from Smartphones pharmaceutical-technology
August 23, 2017
Novartis announced the launch of a mobile research study for people with multiple sclerosis (MS) that collects data via smartphone, without the need for clinic visits.It aims to improve understanding of the daily challenges patients with MS can have and t
Sandoz’s Erelzi available for multiple inflammatory disease treatment in Canada pharmaceutical-technology
August 23, 2017
Novartis division Sandoz has made its Erelzi (etanercept) therapy available for the treatment of multiple inflammatory diseases for patients in Canada.
Novartis launches multiple sclerosis study using data collected from smartphones firstwordpharma
August 23, 2017
Novartis announced the launch of the elevateMS trial to collect data via smartphones, which will provide researchers with new ways to look at how the disease progresses and effectiveness of treatment.
Novartis CEO opens door to cancer patient demanding ‘fair’ CAR-T pricing fiercepharma
August 22, 2017
Novartis CEO Joe Jimenez granted a cancer patient's request for a meeting at the company to discuss CAR-T pricing as its med tisagenlecleucel (CTL019) awaits an FDA decision date in October.
Novartis and Medicines for Malaria Venture launch patient trial in Africa for KAF156, a novel compou worldpharmanews
August 22, 2017
Novartis and Medicines for Malaria Venture (MMV) have launched a patient trial for KAF156, a next-generation antimalarial compound with the potential to treat drug-resistant strains of the malaria parasite.
Novartis and Medicines for Malaria Venture launch patient trial in Africa for KAF156 biospectrumasia
August 22, 2017
Novartis and Medicines for Malaria Venture launch patient trial in Africa for KAF156. The first trial center is operational in Mali and will be followed by sixteen additional centers across a total of nine countries in Africa and Asia over the next few mo
Novartis and MMV launches patient trial in Africa for KAF156 expressbpd
August 22, 2017
KAF156 is first compound from the imidazolopiperazines, a novel class of antimalarials, to enter phase IIb combination studies
Novartis entices UCSF director to senior position at NIBR fiercebiotech
August 18, 2017
Shaun Coughlin will join NIBR's Cambridge campus in November.
After a slow start, Novartis finally gains market traction with heart drug Entresto fiercepharma
August 16, 2017
Novartis CEO Joe Jimenez told investors during a recent earnings call that heart failure drug Entresto is winning over insurers.
Sandoz expands partnership with World Child Cancer, to help children access treatment in four develo worldpharmanews
July 27, 2017
eading charity World Child Cancer, aimed at improving access to treatment and optimizing survival outcomes for children suffering from cancer in four developing countries.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 71 72 Next page